Pilot study of tolerability and effectivity following application of two combination topical acne products clindamycin 1% and 0.025% tretinoin gel (Acnatac Gel), adapalen 0,1% and benzoyl peroxide 2,5% gel (Epiduo Gel).

Trial Profile

Pilot study of tolerability and effectivity following application of two combination topical acne products clindamycin 1% and 0.025% tretinoin gel (Acnatac Gel), adapalen 0,1% and benzoyl peroxide 2,5% gel (Epiduo Gel).

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Oct 2015

At a glance

  • Drugs Clindamycin/tretinoin (Primary) ; Adapalene/benzoyl peroxide
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top